Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 6 recruiting now early-phase tilt small index

Metastatic Brain Tumor: early-phase trial registry

6 of 7 indexed Metastatic Brain Tumor trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #2,497 of 28,707 conditions by registered trial count.

7 US clinical trials · 6 currently recruiting · #2,497 of 28,707 conditions by registered trial count

Metastatic Brain Tumor: 7 US clinical trials tracked, 6 recruiting.

Metastatic Brain Tumor is the subject of 7 registered US clinical trials on ClinicalTrials.gov, 6 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Nationwide Children's Hospital, running 2 of these trials.

Enrollment posture brief

Registry condition metastatic-brain-tumor

OPEN 6 | RECR 86% | LATE 0 | EARLY 3 | RANK #2497 | SPON 2

Nearest open-share peer: Adenovirus (86% recruiting · 7 trials)

Metastatic Brain Tumor (this)86%ACL Tear71.4%ACL57.1%Acute Myelogenous Leukemia42.9%Acne Scars28.6%
Open-enrollment share among volume-matched conditions near Metastatic Brain Tumor

Metastatic Brain Tumor lists 6 open slots (86% of 7 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Metastatic Brain Tumor on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Metastatic Brain Tumor is recruiting above its size-band peers.

    6 of 7 indexed trials (85.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Metastatic Brain Tumor research.

    Nationwide Children's Hospital accounts for 2 of 7 trials (28.6%). 5 distinct sponsors appear on at least one study for this condition label.

  3. Typical Metastatic Brain Tumor enrolment sits around 75 participants.

    Median target enrolment is 75 among the 7 trials that report a genuine target (sentinel values excluded). 4 of those (57.1%) plan for fewer than 100 participants.

  4. Metastatic Brain Tumor splits between interventional and observational designs.

    4 interventional and 3 observational studies make up this index (57.1% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11Phase 22

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 2 2

Named interventions

Most-linked intervention names on Metastatic Brain Tumor records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Neurocognitive battery with quality-of-life assessment Other
1 trials
Resting-state functional connectivity MRI Diagnostic test
1 trials
Olutasidenib + TMZ Drug
1 trials
1-(2-[18F]FLUOROETHYL)-L-Tryptophan Drug
1 trials
CEST-MRF Diagnostic test
1 trials
Brain mapping Diagnostic test
1 trials
Temozolomide (TMZ) Drug
1 trials
Ribociclib Drug
1 trials

US sites by state

Facility locations filed on Metastatic Brain Tumor trials. A trial with sites in several states counts in each.

Washington 3 trials
Texas 3 trials
Pennsylvania 3 trials
Ohio 3 trials
North Carolina 3 trials
Michigan 3 trials
Massachusetts 3 trials
Illinois 3 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Metastatic Brain Tumor page

7 registered trials, 6 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Metastatic Brain Tumor condition card totals 7 registered trials; most-linked intervention Neurocognitive battery with quality-of-life assessment; top US site state Washington. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.